Medical Research
(H05)
990 on File
THE ALLIANCE FOR BENZODIAZEPINE BEST PRACTICES
Financial strength (30%)
92/100
Reliability (20%)
45/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$109K
Total Revenue
$78K
Total Expenses
$50K
Net Assets
1
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
80.8%
Fundraising Efficiency
N/A
Operating Reserve
7.70x
Liability-to-Asset
19.4%
Revenue Diversification
104.5%
Executive Compensation
$0
Compared with Peers
FY 2023
Compared with 1,152 similar organizations
(United States, Medical Research, under $100K in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
80.8% | 80.3% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
16.9% | 12.0% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
2.3% | 0.0% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
7.7 mo | 37.0 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
19.4% | 0.0% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
104.5% | 100.0% |
P10P90
|
Bottom quarter |
|
Surplus margin
Surplus as a share of revenue
|
29.1% | 12.7% |
P10P90
|
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.